Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-25 @ 3:21 PM
Study NCT ID:
NCT00895895
Status:
TERMINATED
Last Update Posted:
2013-01-31
First Post:
2009-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-07
First Submit QC Date:
None
Study First Post Date:
2009-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-21
Results First Submit QC Date:
None
Results First Post Date:
2013-01-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-12-21
Last Update Post Date:
2013-01-31
Last Update Post Date Type:
ESTIMATED